Validierung des deutschsprachigen Menière’s Disease Patient-Oriented Symptom Severity Index

Zusammenfassung

Hintergrund Der Menière’s Disease Patient-Oriented Symptom Severity Index (MD POSI), Version 2, ist ein krankheitsspezifischer Fragebogen zur Erhebung der gesundheitsbezogenen Lebensqualität bei Patienten mit Morbus Menière (MM).

Ziel der Arbeit Validierung und Reliabilitätsprüfung der deutschen Übersetzung des MD POSI.

Material und Methoden Prospektive Datenanalyse eines an Schwindel erkrankten Patientenkollektivs (n=162), welches im Zeitraum von 2005–2019 in der Hals-, Nasen- und Ohrenklinik eines Universitätsklinikums behandelt wurde. Es erfolgte eine klinische Selektion gemäß der neuen Bárány-Klassifikation in einen „definitiven“ und „wahrscheinlichen“ Morbus Menière. Die Lebensqualität wurde mittels der deutschen Übersetzung des MD POSI, der Vertigo Symptom Scale (VSS) und der Short Form-36 (SF-36) untersucht. Die Reliabilität wurde mittels Cronbachs α und Test-Retesting nach 12 Monaten und erneut 14 Tage später überprüft. Es wurde die Inhalts- und Übereinstimmungsvalidität untersucht.

Ergebnisse Cronbach-α-Werte über 0,9 wiesen auf eine gute interne Konsistenz hin. Es gab keinen statistisch signifikanten Unterschied von Baseline bis 12 Monate, mit Ausnahme des Subscores, der die Beschwerden während der Attacke misst. Es zeigten sich signifikant positive Korrelationen zwischen dem VSS-Gesamt/VER/AA und dem Gesamtindex des MD POSI und negativ signifikante Korrelationen mit den SF-36-Domänen körperliche Funktionsfähigkeit, körperliche Rollenfunktion, soziale Funktionsfähigkeit, emotionale Rollenfunktion und psychisches Wohlbefinden. Zusätzlich ergaben sich geringe SRM (standardized response mean) -Werte unter 0,5.

Schlussfolgerung Die deutsche Übersetzung des MD POSI ist ein valides und zuverlässiges Instrument, um den Einfluss von MM auf die krankheitsbezogene Lebensqualität von Patienten zu beurteilen.

Abstract

Background The MD POSI is a disease-specific questionnaire to determine the health-related quality of life (HRQoL) of patients with Menière’s disease (MD).

Objectives Validity and reliability of the German translation of the MD POSI.

Material and Methods Prospective data analysis of a patient group with vertigo (n = 162), which was treated in the otorhinolaryngology of a University Hospital from 2005–2019. A clinical selection was made according to the new Bárány classification in a “definite” and “probable” Menière’s disease. HRQoL was assessed using the German translation of the MD POSI, the Vertigo Symptom Score (VSS) and the Short Form (SF-36). Reliability was measured by Cronbach’s α and test-retesting after 12 months and again 2 weeks later. Content and agreement validity were examined.

Results Cronbach α values greater than 0.9 indicated good internal consistency. There was no statistically significant difference from baseline to 12 months, except for the subscore “during the attack”. There were significant positive correlations between the VSS overall/VER/AA and the overall index of the MD POSI and negative significant correlations with the SF-36 domains physical functioning, physical role functioning, social functioning, emotional role functioning, mental well-being. There were low SRM (standardized response mean) values below 0.5.

Conclusions The German translation of the MD POSI is a valid and reliable instrument to evaluate the impact of MD on patients’ disease-specific quality of life.

Schlüsselwörter

Lebensqualität - Menière’s Disease Patient-Oriented Symptom Severity Index (MD POSI) - Bárány-Klassifikation - Reliabilität - Validität

Keywords

Quality of life - Menière’s Disease Patient-Oriented Symptom Severity Index (MD POSI) - Bárány classification - Reliability - Validity

Publication History

Received: 31 October 2022

Accepted after revision: 11 January 2023

Article published online:
18 April 2023

• Literatur

• 1 Lopez-Escamez JA, Carey J, Chung WH. et al. Diagnostic criteria for Meniere’s disease according to the Classification Committee of the Barany Society. HNO 2017; 65: 887-893 DOI: 10.1007/s00106-017-0387-z. (PMID: 28770282)
• 2 Ballard DP, Sukato DC, Timashpolsky A. et al. Quality-of-Life Outcomes following Surgical Treatment of Meniere’s Disease: A Systematic Review and Meta-analysis. Otolaryngol Head Neck Surg 2019; 160: 232-238 DOI: 10.1177/0194599818803612. (PMID: 30300093)
• 3 Kitahara M. Bilateral aspects of Meniere’s disease. Meniere’s disease with bilateral fluctuant hearing loss. Acta Otolaryngol Suppl 1991; 485: 74-77 DOI: 10.3109/00016489109128046. (PMID: 1843174)
• 4 Huppert D, Strupp M, Brandt T. Long-term course of Meniere’s disease revisited. Acta Otolaryngol 2010; 130: 644-651 DOI: 10.3109/00016480903382808. (PMID: 20001444)
• 5 Salvinelli F, Trivelli M, Greco F. et al. Meniere’s disease: is it a bilateral disease?. Eur Rev Med Pharmacol Sci 1999; 3: 129-133 (PMID: 10827816)
• 6 Paparella MM, Griebie MS. Bilaterality of Meniere’s disease. Acta Otolaryngol 1984; 97: 233-237 DOI: 10.3109/00016488409130984. (PMID: 6720298)
• 7 Greven AJ, Oosterveld WJ. The contralateral ear in Meniere disease. Arch Otolaryngol 1975; 101: 608-612 (PMID: 1164225)
• 8 Kitahara M, Matsubara H, Takeda T. et al. Bilateral Meniere’s disease. Adv Otorhinolaryngol 1979; 25: 117-121 (PMID: 484343)
• 9 Frejo L, Soto-Varela A, Santos-Perez S. et al. Clinical Subgroups in Bilateral Meniere Disease. Front Neurol 2016; 7: 182 DOI: 10.3389/fneur.2016.00182. (PMID: 27822199)
• 10 Anderson JP, Harris JP. Impact of Meniere’s disease on quality of life. Otol Neurotol 2001; 22: 888-894 DOI: 10.1097/00129492-200111000-00030. (PMID: 11698814)
• 11 Basura GJ, Adams ME, Monfared A. et al. Clinical Practice Guideline: Meniere’s Disease. Otolaryngol Head Neck Surg 2020; 162: S1-S55 DOI: 10.1177/0194599820909438. (PMID: 32267799)
• 12 Gates GA, Verrall AM. Validation of the Meniere’s Disease Patient-Oriented Symptom-Severity Index. Arch Otolaryngol Head Neck Surg 2005; 131: 863-867 DOI: 10.1001/archotol.131.10.863. (PMID: 16230587)
• 13 Baumann I. Research on quality of life in ear, nose, and throat medicine. HNO 2009; 57: 855-856 DOI: 10.1007/s00106-009-1971-7. (PMID: 19655120)
• 14 Green JD. Verrall A, Gates GA. Quality of life instruments in Meniere’s disease. Laryngoscope 2007; 117: 1622-1628 DOI: 10.1097/MLG.0b013e3180caa14f. (PMID: 17667131)
• 15 Murphy MP, Gates GA. Measuring the effects of Meniere’s disease: results of the Patient-Oriented Severity Index (MD POSI) version 1. Ann Otol Rhinol Laryngol 1999; 108: 331-337 DOI: 10.1177/000348949910800403. (PMID: 10214778)
• 16 Gates GA. Clinimetrics of Meniere’s disease. Laryngoscope 2000; 110: 8-11 DOI: 10.1097/00005537-200003002-00003. (PMID: 10718407)
• 17 Haas H. Übersetzungsprobleme in der interkulturellen Befragung. In J. Bolten & S. Rathje (Hrsg.), Probleme empirischer Kulturforschung. Interculture-Journal 2009; 10: 61-77
• 18 Souza AC, Alexandre NMC, Guirardello EB. Psychometric properties in instruments evaluation of reliability and validity. Epidemiol Serv Saude 2017; 26: 649-659 DOI: 10.5123/S1679-49742017000300022. (PMID: 28977189)
• 19 Kamalvand A, Ghahraman MA, Jalaie S. Development of the Persian version of the Vertigo Symptom Scale: Validity and reliability. J Res Med Sci 2017; 22: 58 DOI: 10.4103/jrms.JRMS_996_16. (PMID: 28616045)
• 20 Yardley L, Masson E, Verschuur C. et al. Symptoms, anxiety and handicap in dizzy patients: development of the vertigo symptom scale. J Psychosom Res 1992; 36: 731-741 DOI: 10.1016/0022-3999(92)90131-k. (PMID: 1432863)
• 21 Yardley L, Medina SM, Jurado CS. et al. Relationship between physical and psychosocial dysfunction in Mexican patients with vertigo: a cross-cultural validation of the vertigo symptom scale. J Psychosom Res 1999; 46: 63-74 DOI: 10.1016/s0022-3999(98)00056-7.
• 22 Kurre A, van Gool CJ, Bastiaenen CH. et al. Translation, cross-cultural adaptation and reliability of the german version of the dizziness handicap inventory. Otol Neurotol 2009; 30: 359-367 DOI: 10.1097/MAO.0b013e3181977e09. (PMID: 19225437)
• 23 Tschan R, Wiltink J, Best C. et al. Validation of the German version of the Vertigo Symptom Scale (VSS) in patients with organic or somatoform dizziness and healthy controls. J Neurol 2008; 255: 1168-1175 DOI: 10.1007/s00415-008-0863-1. (PMID: 18481033)
• 24 Bulut OC, Wallner F, Oladokun D. et al. Long-term quality of life changes after primary septorhinoplasty. Qual Life Res 2017; DOI: 10.1007/s11136-017-1761-8. (PMID: 29204784)
• 25 Cohen J. Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale,NJ: Lawrence Erlbaum 1988; 567 DOI: 10.4324/9780203771587.
• 26 Strupp M, Brandt T. Diagnosis and treatment of vertigo and dizziness. Dtsch Arztebl Int 2008; 105: 173-180 DOI: 10.3238/arztebl.2008.0173. (PMID: 19629221)
• 27 Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna: Austria; 2020
• 28 Juniper EF, Guyatt GH, Willan A. et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994; 47: 81-87 DOI: 10.1016/0895-4356(94)90036-1. (PMID: 8283197)
• 29 Saman Y, Arshad Q, Dutia M. et al. Stress and the vestibular system. Int Rev Neurobiol 2020; 152: 221-236 DOI: 10.1016/bs.irn.2020.03.013. (PMID: 32450997)
• 30 Correia F, Medeiros AB, Castelhano L. et al. Personality and psychopathology in Meniere's disease. Acta Otorrinolaringol Esp (Engl Ed) 2021; 72: 344-351 DOI: 10.1016/j.otoeng.2020.06.010. (PMID: 34844672)
• 31 van Cruijsen N, Jaspers JP, van de Wiel HB. et al. Psychological assessment of patients with Meniere’s disease. Int J Audiol 2006; 45: 496-502 DOI: 10.1080/14992020600753239.
• 32 Van Cruijsen N, Wit H, Albers F. Psychological aspects of Meniere’s disease. Acta Otolaryngol 2003; 123: 340-347 DOI: 10.1080/0036554021000028125. (PMID: 12737288)
• 33 Kinney SE, Sandridge SA, Newman CW. Long-term effects of Meniere’s disease on hearing and quality of life. Am J Otol 1997; 18: 67-73 (PMID: 8989954)
• 34 Soderman AC, Bagger-Sjoback D, Bergenius J. et al. Factors influencing quality of life in patients with Meniere's disease, identified by a multidimensional approach. Otol Neurotol 2002; 23: 941-948 DOI: 10.1097/00129492-200211000-00022.
• 35 Molnar A, Maihoub S, Mavrogeni P. et al. Depression scores and quality of life of vertiginous patients, suffering from different vestibular disorders. Eur Arch Otorhinolaryngol 2022; 279: 5173-5179 DOI: 10.1007/s00405-022-07366-y.
• 36 Orji F. The Influence of Psychological Factors in Meniere’s Disease. Ann Med Health Sci Res 2014; 4: 3-7 DOI: 10.4103/2141-9248.126601. (PMID: 24669323)
• 37 Olusesi A, Oyeniran O. Persistence of Non-Vertigo Symptoms in Meniere Disease During Remission – A Preliminary Report. Otolaryngol Pol 2020; 74: 31-36 DOI: 10.5604/01.3001.0013.7927. (PMID: 32636348)
• 38 Gustavsen IO, Wilhelmsen K, Goode AP. et al. Dizziness and physical health are associated with pain in dizzy patients-A cross-sectional study. Physiother Res Int 2021; 26: e1923 DOI: 10.1002/pri.1923.
• 39 Jacobi F, Kessler-Scheil S. Epidemiology of mental disorders Frequency and disease burden in Germany. Psychotherapeut 2013; 58: 191-206
• 40 Hapke U, Maske UE, Scheidt-Nave C. et al. Chronic stress among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 749-754 DOI: 10.1007/s00103-013-1690-9.
• 41 Eppelmann L, Parzer P, Salize HJ. et al. Stress, mental and physical health and the costs of health care in German high school students. Eur Child Adolesc Psychiatry 2020; 29: 1277-1287 DOI: 10.1007/s00787-019-01441-2. (PMID: 31811575)
• 42 Oosterloo BC, Homans NC, Baatenburg de Jong RJ. et al. Assessing hearing loss in older adults with a single question and person characteristics; Comparison with pure tone audiometry in the Rotterdam Study. PLoS One 2020; 15: e0228349 DOI: 10.1371/journal.pone.0228349.
• 43 Rohs FR, Langone CA, Coleman RK. Response shift bias: a problem in evaluating nutrition training using self-report measures. J Nutr Educ 2001; 33: 165-170 DOI: 10.1016/s1499-4046(06)60187-5. (PMID: 11953233)
• 44 Teixeira LS, Guimaraes Cavalcante AM. Ménière’s Disease: Epidemiology INTECH 2017; Chapter 3: 31.
• 45 Radtke A, Lempert TE, von Brevern M. Prevalence of Menière’s disease in the general population in Germany Aktuelle Neurologie. 2005; 32 DOI: 10.1055/s-2005-919326.
• 46 Anthoine E, Moret L, Regnault A. et al. Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures. Health Qual Life Outcomes 2014; 12: 176 DOI: 10.1186/s12955-014-0176-2. (PMID: 25492701)
• 47 Pyykko I, Nakashima T, Yoshida T. et al. Meniere’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualisation of endolymphatic hydrops. BMJ Open 2013; 3 DOI: 10.1136/bmjopen-2012-001555. (PMID: 23418296)
• 48 Gurkov R, Hornibrook J. On the classification of hydropic ear disease (Meniere’s disease). HNO 2018; 66: 455-463 DOI: 10.1007/s00106-018-0488-3. (PMID: 29500497)
• 49 Schaaf H, Holtmann H. Management of the patient with Meniere’s disease. Clear diagnosis but vertigo-provoking perspective. HNO 2005; 53: 889-894 DOI: 10.1007/s00106-005-1248-8. (PMID: 15909147)